83 results
Page 2 of 5
6-K
EX-99.1
b4bi85
17 Nov 21
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
6:00am
6-K
EX-99.2
smhi0rri wlt3xopyk
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
S-8
EX-99.1
ol5zgh5g 84
26 Oct 21
Registration of securities for employees
4:07pm
S-8
EX-99.2
e1e6p2ii4 au6ioisttv
26 Oct 21
Registration of securities for employees
4:07pm
S-8
EX-99.3
fbm0zk9 zi
26 Oct 21
Registration of securities for employees
4:07pm
6-K
EX-99.2
h4upwdkz 5krxtz96uv4
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
wt7qmp5aas vg
19 May 21
Current report (foreign)
6:00am
6-K
EX-99.3
q5kn9hqrqc260
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.2
gaa3oofsxnpe8txv5n
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.2
26g3luxtjepycq
25 Mar 21
Publication of the annual report and invitation to the The annual report for the financial year 2020, including a review of figures and performance, is available online at
12:00am
6-K
EX-99.1
ieheoguzgg3zyc 40y34
24 Nov 20
Selvita to acquire Fidelta from Galapagos
7:05am
6-K
EX-99.2
sqxpgst7j1
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
EX-99.1
atz0 9dasni34q
13 Oct 20
Current report (foreign)
6:15am
S-8
EX-99.1
hzo21s1pulse c6
9 Oct 20
Registration of securities for employees
4:32pm